![Enrique Dilone](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Enrique Dilone
Directeur Technique/Scientifique/R&D chez
IMMUNITYBIO, INC.
Profil
Enrique Dilone is currently Director at La Casa de Don Pedro, Inc. and Chief Technology Officer at ImmunityBio, Inc. since 2023.
Formerly, Dr. Dilone was Executive Director-Quality & Analytics at NovaDel Pharma, Inc. from 2007 to 2009, Director-Analytical Operations at Oldtech, Inc. from 2002 to 2006, Senior Vice President-Technical Operations at Amicus Therapeutics, Inc. from 2009 to 2019, and Chief Technology Officer at Prothelia,.
Inc. Education includes undergraduate studies at New York University and graduate and doctorate degrees from Seton Hall University.
Postes actifs de Enrique Dilone
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNITYBIO, INC. | Directeur Technique/Scientifique/R&D | 14/08/2023 |
La Casa de Don Pedro, Inc.
 La Casa de Don Pedro, Inc. Miscellaneous Commercial ServicesCommercial Services Provides adult, alternative education, energy conservation, assistance and childhood programs | Directeur/Membre du Conseil | - |
Anciens postes connus de Enrique Dilone
| Sociétés | Poste | Fin |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | Corporate Officer/Principal | 01/10/2019 |
| NOVADEL PHARMA INC | Corporate Officer/Principal | 01/08/2009 |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | 01/12/2006 |
Prothelia, Inc.
 Prothelia, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops therapies | Directeur Technique/Scientifique/R&D | - |
Formation de Enrique Dilone
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
NovaDel Pharma, Inc.
 NovaDel Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops oral spray formulations | Health Technology |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Develops pharmaceutical products | Health Technology |
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seton Hall University
 Seton Hall University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
La Casa de Don Pedro, Inc.
La Casa de Don Pedro, Inc. Miscellaneous Commercial ServicesCommercial Services Provides adult, alternative education, energy conservation, assistance and childhood programs | Commercial Services |
Prothelia, Inc.
Prothelia, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops therapies | Health Technology |
ImmunityBio, Inc.
 ImmunityBio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for immunogenic mechanisms for defeating cancer and infectious disease | Health Technology |
